XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Inventory (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Raw materials $ 22,006 $ 31,874
Work-in-process 140,370 54,455
Finished goods 36,910 34,630
Total inventory 199,286 120,959
Inventories - current 57,200 41,995 [1]
Inventories-noncurrent 142,086 $ 78,964 [1]
Inventory incurred prior to FDA approval $ 36,700  
Minimum    
Period of lower average per unit cost of materials 12 months  
Maximum    
Period of lower average per unit cost of materials 18 months  
[1] The condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated financial statements at that date.